63 related articles for article (PubMed ID: 32976190)
1. Albumin administration in patients with decompensated liver cirrhosis: a meta-analytic update.
Ashour AA; Atta MA; Sadek KW; Obaid KR; Ashour MA; Ashour A; Danjuma MI; Doi SA; ElZouki AN
Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):479-486. PubMed ID: 32976190
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of long-term albumin therapy in the treatment of decompensated cirrhosis.
Khanna D; Kar P; Sahu P
Indian J Gastroenterol; 2024 Apr; 43(2):494-504. PubMed ID: 38722510
[TBL] [Abstract][Full Text] [Related]
3. Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial.
Pompili E; Baldassarre M; Iannone G; Tedesco G; Nardelli S; Piano S; Alessandria C; Neri S; Foschi FG; Levantesi F; Caraceni P; Bernardi M; Zaccherini G;
Liver Int; 2024 Jun; ():. PubMed ID: 38934515
[TBL] [Abstract][Full Text] [Related]
4. The effect of a low preoperative albumin level on the long-term mortality: a meta-regression analysis.
Chen IW; Wang WT; Hung KC
Surg Today; 2024 May; 54(5):506-507. PubMed ID: 38253896
[No Abstract] [Full Text] [Related]
5. Response to the comments on: The effect of low preoperative albumin on long-term mortality: a meta-regression.
Xu R; Zhang W
Surg Today; 2024 May; ():. PubMed ID: 38761190
[No Abstract] [Full Text] [Related]
6. Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature.
Zaccherini G; Tufoni M; Bernardi M
Hepat Med; 2020; 12():153-172. PubMed ID: 33149707
[TBL] [Abstract][Full Text] [Related]
7. Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.
Frenette C; Kayali Z; Mena E; Mantry PS; Lucas KJ; Neff G; Rodriguez M; Thuluvath PJ; Weinberg E; Bhandari BR; Robinson J; Wedick N; Chan JL; Hagerty DT; Kowdley KV;
J Hepatol; 2021 Feb; 74(2):274-282. PubMed ID: 33038432
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Bound Human Serum Albumin and Systemic Septic Shock.
Johnson AS; Fatemi R; Winlow W
Front Cardiovasc Med; 2020; 7():153. PubMed ID: 33088822
[TBL] [Abstract][Full Text] [Related]
9. Albumin internalizes and inhibits endosomal TLR signaling in leukocytes from patients with decompensated cirrhosis.
Casulleras M; Flores-Costa R; Duran-Güell M; Alcaraz-Quiles J; Sanz S; Titos E; López-Vicario C; Fernández J; Horrillo R; Costa M; de la Grange P; Moreau R; Arroyo V; Clària J
Sci Transl Med; 2020 Oct; 12(566):. PubMed ID: 33087502
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of the serum-ascites albumin gradient in Mexican patients with ascites related to portal hypertension.
Cervantes Pérez E; Cervantes Guevara G; Cervantes Pérez G; Cervantes Cardona GA; Fuentes Orozco C; Pintor Belmontes KJ; Guzmán Ramírez BG; Reyes Aguirre LL; Barbosa Camacho FJ; Bernal Hernández A; González Ojeda A
JGH Open; 2020 Oct; 4(5):838-842. PubMed ID: 33102752
[TBL] [Abstract][Full Text] [Related]
11. Phases of fluid management and the roles of human albumin solution in perioperative and critically ill patients.
Wiedermann CJ
Curr Med Res Opin; 2020 Dec; 36(12):1961-1973. PubMed ID: 33090028
[TBL] [Abstract][Full Text] [Related]
12. A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
China L; Freemantle N; Forrest E; Kallis Y; Ryder SD; Wright G; Portal AJ; Becares Salles N; Gilroy DW; O'Brien A;
N Engl J Med; 2021 Mar; 384(9):808-817. PubMed ID: 33657293
[TBL] [Abstract][Full Text] [Related]
13. Albumin in Advanced Liver Diseases: The Good and Bad of a Drug!
Jagdish RK; Maras JS; Sarin SK
Hepatology; 2021 Nov; 74(5):2848-2862. PubMed ID: 33772846
[TBL] [Abstract][Full Text] [Related]
14. Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications.
Baldassarre M; Naldi M; Zaccherini G; Bartoletti M; Antognoli A; Laggetta M; Gagliardi M; Tufoni M; Domenicali M; Waterstradt K; Paterini P; Baldan A; Leoni S; Bartolini M; Viale P; Trevisani F; Bernardi M; Caraceni P
Hepatology; 2021 Oct; 74(4):2058-2073. PubMed ID: 33710623
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of albumin infusion for overt hepatic encephalopathy: A systematic review and meta-analysis.
Teh KB; Loo JH; Tam YC; Wong YJ
Dig Liver Dis; 2021 Jul; 53(7):817-823. PubMed ID: 34011479
[TBL] [Abstract][Full Text] [Related]
16. European Society of Intensive Care Medicine clinical practice guideline on fluid therapy in adult critically ill patients. Part 1: the choice of resuscitation fluids.
Arabi YM; Belley-Cote E; Carsetti A; De Backer D; Donadello K; Juffermans NP; Hammond N; Laake JH; Liu D; Maitland K; Messina A; Møller MH; Poole D; Mac Sweeney R; Vincent JL; Zampieri FG; AlShamsi F;
Intensive Care Med; 2024 Jun; 50(6):813-831. PubMed ID: 38771364
[TBL] [Abstract][Full Text] [Related]
17. Albumin: a comprehensive review and practical guideline for clinical use.
Abedi F; Zarei B; Elyasi S
Eur J Clin Pharmacol; 2024 Apr; ():. PubMed ID: 38607390
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Post-Operative C-Reactive Protein-Based Inflammatory Biomarkers in Colorectal Cancer Patients: Systematic Review and Meta-Analysis.
Gwenzi T; Zhu A; Schrotz-King P; Schöttker B; Hoffmeister M; Edelmann D; Brenner H
Clin Epidemiol; 2023; 15():795-809. PubMed ID: 37396024
[TBL] [Abstract][Full Text] [Related]
19. Human Albumin Infusion for the Management of Liver Cirrhosis and Its Complications: An Overview of Major Findings from Meta-analyses.
Zheng X; Bai Z; Wang T; Romeiro FG; Mancuso A; Philips CA; Wong YJ; Nery FG; Qi X
Adv Ther; 2023 Apr; 40(4):1494-1529. PubMed ID: 36697778
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of autologous bone marrow cells injected into the liver under the guidance of B‑ultrasound in the treatment of HBV‑related decompensated liver cirrhosis.
Li L; Si Y; Cheng M; Lang L; Li A; Liu B
Exp Ther Med; 2022 Oct; 24(4):633. PubMed ID: 36160909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
